SA
Go ProLog In
KZR
OverviewIntelligenceChart
Q3 2026 EPS Estimate
$-1.05

Analyst Sentiment

Wall St. Consensus
Hold
7 analysts·Limited coverage
57
Score
2 Buy (29%)5 Hold (71%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
229%
Hold
571%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$5.00
-31.4%
Consensus
$7.00
-4.0%
Bull
$21.00
+188.1%
12-Month Target Range7 analysts
$5.00$7.00$21.00
Current $7.29Consensus
Current Price
$7.29
Above Consensus
$0.29

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

No analyst estimates available

Earnings Surprises

Earnings surprise history unavailable.

Recent Analyst Actions

Oct 17, 2025Wells Fargo
Kezar Life Sciences price target lowered to $5 from $7 at Wells Fargo
Target:$5.00
+19.9%from $4.17
Oct 17, 2025Jefferies
Kezar Life Sciences downgraded to Hold from Buy at Jefferies
Target:$7.00
+67.9%from $4.17
Dec 19, 2024Wells Fargo
Kezar Life Sciences price target lowered to $9 from $11 at Wells Fargo
Target:$9.00
+43.8%from $6.26
Aug 12, 2022H.C. Wainwright
HC Wainwright & Co. Maintains Buy on Kezar Life Sciences, Raises Price Target to $21
Target:$21.00
+115.2%from $9.76
May 4, 2022Wells Fargo
Wells Fargo Maintains Overweight on Kezar Life Sciences, Lowers Price Target to $14
Target:$14.00
+76.4%from $7.94

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance